findmyKOL

Ariss Derhovanessian, MD

Basic profile

UCLA Health

ORCIDNone on fileNPI
RegionLos Angeles, CA · WestSpecialtyPulmonary DiseaseFocusRespiratory
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Ariss Derhovanessian is a Respiratory physician affiliated with UCLA Health. OpenAlex indexes 67 publications with 1,939 citations (h-index 24).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
67publications

Distinct works indexed by OpenAlex.

1,939citations

Total citations across indexed works.

24h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    32%
    Short-acting sulfonamides11.1%
    Sulfamethoxazole-Trimethoprim100%
    Part D38 patients
    Macrolide Antimicrobial9.5%
    Azithromycin100%
    Part D34 patients

    + 3 more classes in this area

  • Metabolism & gastrointestinal

    22.5%
    Corticosteroid12.1%
    Prednisone100%
    Part D44 patients
    Proton pump inhibitor8.1%
    Pantoprazole Sodium89%Omeprazole11%
    Part D<11 patients

    + 2 more classes in this area

  • Cancer & immunology

    18.2%
    Calcineurin inhibitor10.8%
    Tacrolimus100%
    Part D22 patients
    Kinase inhibitor6.6%
    Ofev69%Sirolimus31%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”